Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgaf157 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Yeliz Bulut und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Endocrinology, Copenhagen University Hospital-Rigshospitalet, Copenhagen DK-2100, Denmark. Hauptthemen laut MEDLINE: Leydig Cells, Androgens. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Novo Nordisk Foundation, Health Research Foundation of the Capital Region in Denmark.
Abstract (Originalsprache)
Background and Objectives A few studies have explored the impairment of pituitary gonadotroph and Leydig cell function in men who recently ceased illicit androgen use, as assessed by stimulation tests. However, the capacity of the pituitary-testis axis in previous users who discontinued androgen use years ago remains unclear. This study evaluated the pituitary-testis-axis capacity in previous illicit androgen users and nonusers.
Methods
We conducted a cross-sectional study of recreational strength training men with (n = 30) and without (n = 26) a history of illicit androgen use. Previous users were subdivided into 2 subgroups based on detectable (group 1, n = 17) and undetectable (group 2, n = 13) performance-enhancing drugs in the urine. We performed gonadotropin-releasing hormone and human chorionic gonadotropin (hCG) stimulation tests. Serum LH was measured with immunoassay, total testosterone, and insulin-like factor 3 with liquid chromatography-tandem mass spectrometry. Sexual function was assessed using the 15-question International Index of Erectile Function questionnaire.
Results
Elapsed duration since androgen cessation, geometric mean (95% confidence interval), was 1.9 (1.2; 3.0) years in previous androgen users. The mean (SD) age of all participants was 33 (8) years. Testosterone secretion after hCG injection was lower in previous users than nonusers: group 1 difference, −6.4 (−11.3; −1.5) nmol/L, (P = .031); group 2 difference, −14.2 (−19.5; −8.8) nmol/L, (P < .001). LH secretion did not differ between the groups. Multivariate linear regressions using erectile function as a dependent variable revealed that higher testosterone secretion during the hCG test (P = .046) was independently associated with better erectile function, whereas baseline serum testosterone (P = .780) and estradiol (P = .405) were not.
Conclusion
Previous illicit androgen users exhibited decreased Leydig cell capacity 2 years after androgen cessation, which potentially influences erectile function.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology and Endocrinology, Copenhagen University Hospital-Rigshospitalet, Copenhagen DK-2100, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
- Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital-Rigshospitalet, Copenhagen DK-2100, Denmark.
- Center for Preventive Doping Research, German Sport University, Cologne 50933, Germany.
- Department of Endocrinology, Odense University Hospital, Odense DK-5000, Denmark.
- Faculty of Health Sciences, University of Southern Denmark, Odense DK-5230, Denmark.
ORCID-Profile: Yeliz Bulut, Niels Brandt-Jacobsen, Jan Frystyk, Jakob Albrethsen, Niels Jørgensen, Anders Juul, Caroline Kistorp, Jon Jarløv Rasmussen
Förderung
- Novo Nordisk Foundation
- Health Research Foundation of the Capital Region in Denmark
Zitieren
APA
Bulut, Y., Brandt-Jacobsen, N., Madsen, R., Thevis, M., Frystyk, J., Albrethsen, J., Jørgensen, N., Juul, A., Kistorp, C., & Rasmussen, J. J. (2025). Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgaf157
Vancouver
Bulut Y, Brandt-Jacobsen N, Madsen R, Thevis M, Frystyk J, Albrethsen J, et al. Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgaf157
BibTeX
@article{Bulut2025,
author = {Bulut, Yeliz and Brandt-Jacobsen, Niels and Madsen, Rasmus and Thevis, Mario and Frystyk, Jan and Albrethsen, Jakob and Jørgensen, Niels and Juul, Anders and Kistorp, Caroline and Rasmussen, Jon Jarløv},
title = {Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgaf157}
}
EUVIMED